Skip to main content
. Author manuscript; available in PMC: 2016 May 13.
Published in final edited form as: Am J Hematol. 2014 Aug 27;89(11):E212–E217. doi: 10.1002/ajh.23819

Table 5.

Final multiple variable negative binomial regression models for prospective pain and ACS events in the Sleep and Asthma Cohort Study Cohort Study when spirometry results and skin testing are included in the regression model. The minimum age of the cohort, four years, decreased the number of children with evaluable spirometry and skin testing results. Participants with complete data on spirometry and skin tests (n= 130).

Outcome Covariate* Incidence Rate Ratio 95% Conf. Interval P**
Prospective ACS§ Gender (female) 1.54 (0.94, 2.53) 0.089
ACS episode before age 4 2.56 (1.59, 4.12) <0.001
Wheezing caused shortness of breath 1.78 (1.02, 3.09) 0.042
Wheezing after exercise 1.31 (0.78, 2.22) 0.312
Two or more positive skin tests 1.87 (1.16, 3.00) 0.010
FEV1/FVC <LLN 0.86 (0.48, 1.53) 0.606
Bronchodilator response ≥ 12% 1.18 (0.66, 2.11) 0.581
Prospective Pain§ Age of first contact 1.05 (0.99, 1.12) 0.116
Hemoglobin (g/dl)# 1.32 (1.09, 1.60) 0.004
Mother has asthma 1.50 (0.73, 3.09) 0.273
Two or more positive skin tests 1.14 0.68, 1.92) 0.628
FEV1/FVC <LLN 0.76 (0.42, 1.39) 0.377
Bronchodilator response ≥ 12% 0.89 (0.48, 1.66) 0.720
*

Negative Binomial regression model with adjustment for over dispersion. Two-tailed significance values.

§

130 patients with non-missing data in SAC cohort with skin tests, bronchodilator response, and lower airway obstruction, defined as the forced expired volume in 1 second/forced vital capacity (FEV1/FVC) < lower limit of normal (LLN) according these equations provided by Quanjer et al.14